We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+23.31%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$916M
AUM Growth
+$200M
Cap. Flow
+$82.6M
Cap. Flow %
9.02%
Top 10 Hldgs %
26.61%
Holding
112
New
9
Increased
29
Reduced
6
Closed
6

Top Buys

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$17.7M
2
TRN icon
Trinity Industries
TRN
+$17.1M
3
SPLK
Splunk Inc
SPLK
+$9.6M
4
NRG icon
NRG Energy
NRG
+$6.27M
5
XPO icon
XPO
XPO
+$6.11M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$15.5M
2
MDVN
MEDIVATION, INC.
MDVN
+$6.68M
3
AKBA icon
Akebia Therapeutics
AKBA
+$3.68M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$1.92M
5
ARWR icon
Arrowhead Research
ARWR
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 31.22%
2 Technology 16.49%
3 Consumer Discretionary 14.21%
4 Industrials 9.04%
5 Energy 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLTC
26
DELISTED
Linear Technology Corp
LLTC
$13.3M 1.46%
292,600
– –
EOG icon
27
EOG Resources
EOG
$77.5B
$13.3M 1.46%
144,800
– –
ASML icon
28
ASML
ASML
$634B
$12.9M 1.4%
119,200
+25,400
+27% +$2.58M
NRG icon
29
NRG Energy
NRG
$28.3B
$12.5M 1.37%
465,300
+211,900
+84% +$6.27M
SYNA icon
30
Synaptics
SYNA
$4.25B
$12.5M 1.36%
181,600
+21,200
+13% +$1.42M
TTPH
31
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$11.5M 1.26%
14,500
-545
-4% -$293K
NVAX icon
32
Novavax
NVAX
$1.22B
$11.3M 1.24%
95,435
– –
CBI
33
DELISTED
Chicago Bridge & Iron Nv
CBI
$11M 1.2%
262,000
+68,200
+35% +$3.36M
ININ
34
DELISTED
Interactive Intelligence Group, inc.
ININ
$10.6M 1.16%
222,200
– –
LYB icon
35
LyondellBasell Industries
LYB
$19.5B
$10.6M 1.16%
133,900
– –
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$10.5M 1.15%
372,400
– –
CCI icon
37
Crown Castle
CCI
$33.4B
$10.3M 1.12%
130,700
– –
STML
38
DELISTED
Stemline Therapeutics, Inc.
STML
$10.2M 1.12%
600,500
+20,700
+4% +$299K
PCYC
39
DELISTED
PHARMACYCLICS INC
PCYC
$10.1M 1.1%
82,600
– –
STKL
40
DELISTED
SunOpta
STKL
$10.1M 1.1%
849,600
– –
CXP
41
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$9.98M 1.09%
393,800
– –
TSLA icon
42
Tesla
TSLA
$1.22T
$9.81M 1.07%
661,500
+267,000
+68% +$4.17M
BWA icon
43
BorgWarner
BWA
$13.2B
$9.45M 1.03%
195,392
+52,710
+37% +$2.57M
MEOH icon
44
Methanex
MEOH
$4.27B
$9.23M 1.01%
201,300
– –
SPLK
45
DELISTED
Splunk Inc
SPLK
$9.22M 1.01%
+156,400
New +$9.6M
UFS
46
DELISTED
DOMTAR CORPORATION (New)
UFS
$8.79M 0.96%
218,600
+20,000
+10% +$787K
LUMO
47
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$8.57M 0.94%
23,967
– –
AYR
48
DELISTED
Aircastle Ltd
AYR
$8.54M 0.93%
399,600
– –
TEX icon
49
Terex
TEX
$7.11B
$8.46M 0.92%
303,500
– –
VMW
50
DELISTED
VMware, Inc
VMW
$8.07M 0.88%
97,800
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Eventide Asset Management held 112 positions worth $916M, up 28% from $716M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $82.6M of net new capital in Q4 2014, opening 9 new positions and adding to 29 existing holdings. Its largest new stake was Mandiant, Inc. Common Stock: 575,600 shares worth $18.2M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $15.5M trimmed.

  • Eventide Asset Management's largest Q4 2014 buy was Mandiant, Inc. Common Stock: 575,600 shares worth $18.2M.
  • Eventide Asset Management added most to NRG Energy in Q4 2014, an estimated $6.27M increase.
  • Eventide Asset Management's biggest Q4 2014 reduction was Agios Pharmaceuticals, cutting an estimated $15.5M.
  • Eventide Asset Management fully exited Akebia Therapeutics in Q4 2014, selling an estimated $3.68M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $916M portfolio in Q4 2014.
  • Eventide Asset Management opened 9 new positions and closed 6 in Q4 2014.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $916M.

Based on Eventide Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.